To Russian Federation registered a new drug against hepatitis B

The Russian drug against the hepatitis B "Antigep-Neo" passed clinical tests. He received the registration certificate, is reported in the telegram-channel of GARAGE COOPERATIVE "ROSTEKH"". Company FEDERAL STATE UNITARY ENTERPRISE "SCIENTIFIC PRODUCTION ASSOCIATION "MIKROGEN" MINISTRY OF HEALTH RUSSIA, entering holding JOINT-STOCK COMPANY "NATSIONALNAYA IMMUNOBIOLOGICHESKAYA COMPANY" GARAGE COOPERATIVE "ROSTEKH", received the certificate Ministry of Health of the Russian Federation about registration medicines against hepatitis B", – it is noted in the statement. It is specified that this preparation was the first intravenous specific immunoglobulin for hepatitis prevention at children and adults to Russian Federation. Citizens with existence of the increased risk also can accept it...